(-)-demecolcine increases expression EXP 6480464 Demecolcine results in increased expression of PTAFR mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PTAFR mRNA CTD PMID:22079256 (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of PTAFR mRNA CTD PMID:18247414 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of PTAFR mRNA CTD PMID:23825647 1-naphthyl isothiocyanate increases expression ISO RGD:61897 6480464 1-Naphthylisothiocyanate results in increased expression of PTAFR mRNA CTD PMID:25380136 1-O-palmitoyl-2-O-(5-oxovaleryl)-sn-glycero-3-phosphocholine affects binding EXP 6480464 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine binds to PTAFR protein CTD PMID:16386258 1-O-palmitoyl-2-O-(5-oxovaleryl)-sn-glycero-3-phosphocholine multiple interactions EXP 6480464 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine inhibits the reaction [Platelet Activating Factor binds to PTAFR protein] CTD PMID:16386258 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of PTAFR mRNA CTD PMID:21826169 17beta-estradiol multiple interactions ISO RGD:61897 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PTAFR mRNA CTD PMID:32741896 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of PTAFR mRNA CTD PMID:30165855 17beta-estradiol 3-benzoate multiple interactions ISO RGD:61897 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PTAFR mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:61897 6480464 Tetrachlorodibenzodioxin results in increased expression of PTAFR mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:61897 6480464 Tetrachlorodibenzodioxin results in decreased expression of PTAFR mRNA CTD PMID:33387578 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine multiple interactions EXP 6480464 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine inhibits the reaction [Platelet Activating Factor binds to PTAFR protein] more ... CTD PMID:11529688 , PMID:16386258 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine increases expression ISO RGD:61897 6480464 Platelet Activating Factor results in increased expression of PTAFR mRNA CTD PMID:10447766 , PMID:9065783 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine increases phosphorylation ISO RGD:61897 6480464 Platelet Activating Factor results in increased phosphorylation of PTAFR protein CTD PMID:11297424 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine multiple interactions ISO RGD:61897 6480464 bepafant inhibits the reaction [Platelet Activating Factor results in increased expression of PTAFR mRNA] more ... CTD PMID:11297424 more ... 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine increases expression EXP 6480464 Platelet Activating Factor results in increased expression of PTAFR mRNA CTD PMID:16386258 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine affects binding EXP 6480464 Platelet Activating Factor binds to PTAFR protein CTD PMID:11529688 , PMID:16386258 2-naphthylamine decreases expression EXP 6480464 2-Naphthylamine results in decreased expression of PTAFR mRNA CTD PMID:18247414 acetamide increases expression ISO RGD:61897 6480464 acetamide results in increased expression of PTAFR mRNA CTD PMID:31881176 acrolein multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of PTAFR mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of PTAFR mRNA CTD PMID:32699268 acrylamide decreases expression ISO RGD:61897 6480464 Acrylamide results in decreased expression of PTAFR mRNA CTD PMID:28959563 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of PTAFR mRNA CTD PMID:21641981 , PMID:22100608 aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of PTAFR gene CTD PMID:27153756 albuterol increases expression EXP 6480464 Albuterol results in increased expression of PTAFR protein CTD PMID:18362475 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of PTAFR mRNA CTD PMID:33167477 alpha-pinene multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of PTAFR mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of PTAFR mRNA CTD PMID:32699268 ammonium chloride affects expression ISO RGD:61897 6480464 Ammonium Chloride affects the expression of PTAFR mRNA CTD PMID:16483693 amphetamine increases expression ISO RGD:61897 6480464 Amphetamine results in increased expression of PTAFR mRNA CTD PMID:30779732 antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of PTAFR mRNA CTD PMID:24449571 Apafant multiple interactions EXP 6480464 [WEB 2086 binds to and results in decreased activity of PTAFR protein] which results in decreased susceptibility to lipoxin A4, WEB 2086 binds to and results in decreased activity of PTAFR protein CTD PMID:7602232 , PMID:8666909 arachidonic acid multiple interactions ISO RGD:61897 6480464 [Docosahexaenoic Acids co-treated with Arachidonic Acid] affects the expression of PTAFR mRNA, Arachidonic Acid inhibits the reaction [1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine results in increased expression of PTAFR mRNA] CTD PMID:17515866 aristolochic acid increases expression EXP 6480464 aristolochic acid I results in increased expression of PTAFR mRNA CTD PMID:33212167 asbestos increases expression EXP 6480464 Asbestos results in increased expression of PTAFR mRNA CTD PMID:22398240 avobenzone increases expression EXP 6480464 avobenzone results in increased expression of PTAFR mRNA CTD PMID:31016361 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of PTAFR mRNA CTD PMID:18247414 benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of PTAFR 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of PTAFR promoter CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of PTAFR mRNA CTD PMID:21871943 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PTAFR mRNA CTD PMID:21826169 bisphenol A decreases expression ISO RGD:61897 6480464 bisphenol A results in decreased expression of PTAFR mRNA CTD PMID:34947998 bisphenol A increases expression ISO RGD:61897 6480464 bisphenol A results in increased expression of PTAFR mRNA CTD PMID:25181051 bleomycin A2 increases expression ISO RGD:62190 6480464 Bleomycin results in increased expression of PTAFR mRNA CTD PMID:30825431 bleomycin A2 multiple interactions ISO RGD:62190 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of PTAFR mRNA], lenabasum inhibits the reaction [Bleomycin results in increased expression of PTAFR mRNA] CTD PMID:30825431 cadmium atom multiple interactions EXP 6480464 [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of PTAFR mRNA CTD PMID:21481475 calcium atom multiple interactions ISO RGD:61897 6480464 RGS4 protein inhibits the reaction [PTAFR protein affects the localization of and affects the abundance of Calcium] CTD PMID:11297424 calcium(0) multiple interactions ISO RGD:61897 6480464 RGS4 protein inhibits the reaction [PTAFR protein affects the localization of and affects the abundance of Calcium] CTD PMID:11297424 cannabidiol multiple interactions ISO RGD:62190 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of PTAFR mRNA] CTD PMID:30825431 carbon nanotube increases expression ISO RGD:62190 6480464 Nanotubes more ... CTD PMID:25554681 carvedilol multiple interactions ISO RGD:61897 6480464 Carvedilol inhibits the reaction [Arginine results in increased expression of PTAFR mRNA] CTD PMID:32569593 chlorpyrifos increases expression ISO RGD:62190 6480464 Chlorpyrifos results in increased expression of PTAFR mRNA CTD PMID:32715474 chlorpyrifos decreases methylation ISO RGD:61897 6480464 Chlorpyrifos results in decreased methylation of PTAFR gene CTD PMID:32905263 choline multiple interactions ISO RGD:62190 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PTAFR mRNA CTD PMID:20938992 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of PTAFR mRNA CTD PMID:27392435 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of PTAFR mRNA CTD PMID:27392435 Cuprizon increases expression ISO RGD:61897 6480464 Cuprizone results in increased expression of PTAFR mRNA CTD PMID:27523638 dexamethasone decreases expression ISO RGD:61897 6480464 Dexamethasone results in decreased expression of PTAFR mRNA CTD PMID:10447766 dextran sulfate multiple interactions ISO RGD:62190 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PTAFR mRNA CTD PMID:29950665 dichlorine increases expression ISO RGD:61897 6480464 Chlorine results in increased expression of PTAFR mRNA CTD PMID:18636392 dichlorine multiple interactions ISO RGD:61897 6480464 [Ozone co-treated with Chlorine] affects the expression of PTAFR mRNA CTD PMID:18636392 elemental selenium multiple interactions EXP 6480464 [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of PTAFR mRNA CTD PMID:21481475 ethanol multiple interactions ISO RGD:62190 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of PTAFR mRNA CTD PMID:30517762 ethyl methanesulfonate increases expression EXP 6480464 Ethyl Methanesulfonate results in increased expression of PTAFR mRNA CTD PMID:23649840 fenvalerate increases expression ISO RGD:61897 6480464 fenvalerate results in increased expression of PTAFR mRNA CTD PMID:30307764 flavonoids increases expression ISO RGD:61897 6480464 Flavonoids results in increased expression of PTAFR mRNA CTD PMID:18035473 folic acid multiple interactions ISO RGD:62190 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PTAFR mRNA CTD PMID:20938992 folic acid increases expression ISO RGD:62190 6480464 Folic Acid results in increased expression of PTAFR mRNA CTD PMID:25629700 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of PTAFR mRNA CTD PMID:23649840 gentamycin decreases expression ISO RGD:61897 6480464 Gentamicins results in decreased expression of PTAFR mRNA CTD PMID:33387578 indometacin decreases expression ISO RGD:61897 6480464 Indomethacin results in decreased expression of PTAFR mRNA CTD PMID:9065783 L-arginine multiple interactions ISO RGD:61897 6480464 Carvedilol inhibits the reaction [Arginine results in increased expression of PTAFR mRNA] CTD PMID:32569593 L-arginine increases expression ISO RGD:61897 6480464 Arginine results in increased expression of PTAFR mRNA CTD PMID:32569593 L-methionine multiple interactions ISO RGD:62190 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PTAFR mRNA CTD PMID:20938992 lipopolysaccharide increases expression ISO RGD:61897 6480464 Lipopolysaccharides results in increased expression of PTAFR mRNA CTD PMID:9065783 lipoxin A4 multiple interactions EXP 6480464 [WEB 2086 binds to and results in decreased activity of PTAFR protein] which results in decreased susceptibility to lipoxin A4 CTD PMID:7602232 monosodium L-glutamate decreases expression ISO RGD:62190 6480464 Sodium Glutamate results in decreased expression of PTAFR mRNA CTD PMID:20111022 N-formyl-L-methionyl-L-leucyl-L-phenylalanine multiple interactions EXP 6480464 PTAFR protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of SELP protein] CTD PMID:11116075 N-nitrosodimethylamine increases expression ISO RGD:61897 6480464 Dimethylnitrosamine results in increased expression of PTAFR mRNA CTD PMID:25380136 nickel atom increases expression EXP 6480464 Nickel results in increased expression of PTAFR mRNA CTD PMID:24768652 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of PTAFR mRNA CTD PMID:18247414 nicotine increases expression EXP 6480464 Nicotine results in increased expression of PTAFR mRNA CTD PMID:23825647 o-anisidine affects expression EXP 6480464 2-anisidine affects the expression of PTAFR mRNA CTD PMID:28089782 ozone multiple interactions ISO RGD:61897 6480464 [Ozone co-treated with Chlorine] affects the expression of PTAFR mRNA CTD PMID:18636392 ozone multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of PTAFR mRNA more ... CTD PMID:32699268 paracetamol decreases expression ISO RGD:62190 6480464 Acetaminophen results in decreased expression of PTAFR mRNA CTD PMID:17585979 paracetamol decreases expression ISO RGD:61897 6480464 Acetaminophen results in decreased expression of PTAFR mRNA CTD PMID:33387578 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PTAFR mRNA CTD PMID:22230336 paracetamol affects expression ISO RGD:62190 6480464 Acetaminophen affects the expression of PTAFR mRNA CTD PMID:17562736 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:61897 6480464 RGS4 protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of PTAFR protein] CTD PMID:11297424 phorbol 13-acetate 12-myristate increases phosphorylation ISO RGD:61897 6480464 Tetradecanoylphorbol Acetate results in increased phosphorylation of PTAFR protein CTD PMID:11297424 potassium chromate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PTAFR mRNA CTD PMID:22079256 potassium chromate increases expression EXP 6480464 potassium chromate(VI) results in increased expression of PTAFR mRNA CTD PMID:22079256 selenium atom multiple interactions EXP 6480464 [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of PTAFR mRNA CTD PMID:21481475 silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of PTAFR mRNA, Silicon Dioxide results in increased expression of PTAFR mRNA CTD PMID:25351596 , PMID:25895662 silicon dioxide increases expression ISO RGD:62190 6480464 Silicon Dioxide results in increased expression of PTAFR mRNA CTD PMID:29341224 silicon dioxide increases expression ISO RGD:61897 6480464 Silicon Dioxide results in increased expression of PTAFR mRNA CTD PMID:21602193 , PMID:22431001 simvastatin decreases expression ISO RGD:61897 6480464 Simvastatin results in decreased expression of PTAFR mRNA CTD PMID:16414398 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of PTAFR mRNA CTD PMID:34032870 testosterone multiple interactions ISO RGD:61897 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PTAFR mRNA CTD PMID:32741896 tetrachloromethane increases activity ISO RGD:61897 6480464 Carbon Tetrachloride results in increased activity of PTAFR protein CTD PMID:12873816 , PMID:16521183 tetrachloromethane multiple interactions ISO RGD:62190 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of PTAFR mRNA CTD PMID:30517762 tetrachloromethane increases expression ISO RGD:61897 6480464 Carbon Tetrachloride results in increased expression of PTAFR mRNA CTD PMID:12873816 more ... tetrachloromethane multiple interactions ISO RGD:61897 6480464 Carbon Tetrachloride promotes the reaction [Platelet Activating Factor binds to PTAFR protein] CTD PMID:18205269 thioacetamide increases expression ISO RGD:61897 6480464 Thioacetamide results in increased expression of PTAFR mRNA CTD PMID:34492290 titanium dioxide multiple interactions ISO RGD:62190 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PTAFR mRNA CTD PMID:29950665 tris(2-butoxyethyl) phosphate affects expression EXP 6480464 tris(2-butoxyethyl) phosphate affects the expression of PTAFR mRNA CTD PMID:29024780 valproic acid increases methylation EXP 6480464 Valproic Acid results in increased methylation of PTAFR gene CTD PMID:29154799 vinclozolin increases methylation ISO RGD:61897 6480464 vinclozolin results in increased methylation of PTAFR gene CTD PMID:31079544 vincristine increases expression EXP 6480464 Vincristine results in increased expression of PTAFR mRNA CTD PMID:23649840 zileuton multiple interactions EXP 6480464 zileuton binds to and results in decreased activity of PTAFR protein, zileuton inhibits the reaction [Platelet Activating Factor binds to PTAFR protein] CTD PMID:11529688
